Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
68
NCT04496596
Study of Suramin in Subjects With Furosemide-Resistant AKI
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 13, 2020
Completion: Dec 22, 2023